申请人:IMTM GmbH
公开号:EP2418196A1
公开(公告)日:2012-02-15
The invention relates to compounds of the general formula (I)
or the acid addition salts thereof with organic and/or inorganic acids; as well as to the use of the compounds of the general formula (1) in the medical field, specifically for use in the suppression of DNA synthesis and inflammatory cytokine production as well as in the stimulation of anti-inflammatory cytokine production in vitro and in vivo. The invention also relates to pharmaceutically effective compositions comprising at least one compound of the general formula (I), optionally together with one or more pharmaceutically acceptable carrier(s), auxiliary substance(s) and/or adjuvant(s) or cosmetically effective compositions comprising at least one compound of the general formula (I), optionally in combination with one or more cosmetically acceptable carrier(s), auxiliary substance(s) and/or adjuvant(s).
本发明涉及通式 (I) 的化合物
或其与有机酸和/或无机酸的酸加成盐;以及通式(1)化合物在医学领域的用途,特别是用于抑制 DNA 合成和炎症细胞因子的产生,以及在体外和体内刺激抗炎细胞因子的产生。本发明还涉及有效的药用组合物,该组合物包含至少一种通式(I)的化合物,可选择与一种或多种药学上可接受的载体、辅助物质和/或佐剂一起使用;或有效的化妆品组合物,该组合物包含至少一种通式(I)的化合物,可选择与一种或多种化妆品上可接受的载体、辅助物质和/或佐剂一起使用。